| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |